Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;7(6):709-22.
doi: 10.1586/eri.09.44.

Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis

Affiliations
Review

Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis

Rachael J Thomas et al. Expert Rev Anti Infect Ther. 2009 Aug.

Abstract

Anaplasma phagocytophilum, Ehrlichia chaffeensis and Ehrlichia ewingii are emerging tick-borne pathogens and are the causative agents of human granulocytic anaplasmosis, human monocytic ehrlichiosis and E. ewingii ehrlichiosis, respectively. Collectively, these are referred to as human ehrlichioses. These obligate intracellular bacterial pathogens of the family Anaplasmataceae are transmitted by Ixodes spp. or Amblyomma americanum ticks and infect peripherally circulating leukocytes to cause infections that range in clinical spectra from asymptomatic seroconversion to mild, severe or, in rare instances, fatal disease. This review describes: the ecology of each pathogen; the epidemiology, clinical signs and symptoms of the human diseases that each causes; the choice methods for diagnosing and treating human ehrlichioses; recommendations for patient management; and is concluded with suggestions for potential future research.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Number of human monocytic ehrlichiosis, Ehrlichia ewingii ehrlichiosis, human granulocytic anaplasmosis and undetermined human ehrlichiosis cases per year (2003–2008)
Undetermined cases occur when all clinical criteria support Ehrlichia spp./Anaplasma phagocytophilum infection, but there is a lack of sufficient clarity to definitively classify the causative agent (e.g., morulae may have been identified in white cells in the absence of other supportive laboratory results). EEE: Ehrlichia ewingii ehrlichiosis; HGA: Human granulocytic anaplasmosis; HME: Human monocytic ehrlichiosis; UD: Undetermined. Data taken from [20].
Figure 2
Figure 2. Examples of Anaplasma phagocytophilum and Ehrlichia chaffeensis morulae in peripheral blood smears and tissue culture cells
(A & B) Anaplasma phagocytophilum and (C & D) Ehrlichia chaffeensis morulae within peripheral blood leukocytes of (A & C) infected human patients and (B & D) cultivated in vitro in (B) HL-60 human promyelocytic cells or (D) canine DH82 histiocytic lymphoma cells. Representative morulae are indicated by arrows. (A & C) Wright stain, original magnification ×1000, (B & D) LeukoStat stain, original magnification ×1000. (E & F) Electron micrographs of A. phagocytophilum-infected HL-60 cells. (E) A. phagocytophilum exhibits a biphasic developmental cycle and transitions between two distinct morphological forms, the dense cored cell (DC) and reticulate cell (RC); original magnification ×8200. Arrows and arrowheads delineate representative morulae containing DC or RC, respectively. (F) An arrow points to an A. phagocytophilum DC bound to the surface of and inducing its own phagocytic uptake by a HL-60 cell; original magnification ×26,500. Electron micrographs are provided by Matthew J Troese of Virginia Commonwealth University (VA, USA).

References

    1. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol. 1991;29(12):2838–2842. Represents the discovery of Ehrlichia chaffeensis as a causative agent of human monocytic ehrlichiosis.

    1. Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N. Engl. J. Med. 1999;341(3):148–155. First report of Ehrlichia ewingii infection in humans

    1. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 1994;32(3):589–595. Initial identification of what would eventually be named Anaplasma phagocytophilum as the causative agent of human granulocytic anaplasmosis (formerly human granulocytic ehrlichiosis)

    1. Foggie A. Studies on the infectious agent of tick-borne fever and sheep. J. Pathol. Bacteriol. 1951;63:1–15. - PubMed
    1. Gribble DH. Equine ehrlichiosis. J. Am. Vet. Med. Assoc. 1969;155:462–469. - PubMed

Publication types

MeSH terms